Xeris Pharmaceuticals' Convertible Note - II Round

Xeris Pharmaceuticals raised a round of funding on January 07, 2015.

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…

Articles about Xeris Pharmaceuticals' Convertible Note - II Round: